Genomic instability and cancer

Mutation Research-DNA Repair

Volumn 337, Issue 1, 1995, Pages 1-7

  Tlsty, Thea D ^a,b   Briot, Amy ^a   Gualberto, Antonio ^a   Hall, Ingrid ^b   Hess, Suzanne ^a   Hixon, Mary ^b   Kuppuswamy, Dhan ^a   Romanov, Serge ^a   Sage, Marijke ^a   White, Alicia ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Genomic instability

Indexed keywords

CANCER; CANCER GROWTH; CARCINOGENICITY; CELL CYCLE; GENE AMPLIFICATION; GENE CONTROL; GENETIC STABILITY; GENOME; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMAL; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASES; DNA DAMAGE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMAN; MUTATION;

EID: 0029000925     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/0921-8777(95)00016-D     Document Type: Short Survey

References (52)

1. Metaphase chromosome anomaly: association with drug resistance and cell-specific products
2. The relevance of the nuclear division cycle in radiosensitivity in yeast
3. Cyclic variations in killing and ‘petite’ mutagenesis induced by ultraviolet light in synchronized yeast strains
4. Correlation of dihydrofolate reductase elevation with gene amplification in a homogeneously staining chromosomal region in L5178Y cells
5. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
6. Comparison of spontaneous mutation rates of normal and chemically transformed human skin fibroblasts
7. A genetic model for colorectal tumorigenesis
8. The experimental study of tumor progression a review
9. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2
10. Amplification of DNA sequences in mammalian cells
11. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
12. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
13. Cell cycle control and cancer
14. Checkpoints: Controls that ensure the order of cell cycle events
15. Cyclins and cancer II: cyclin D and CDK inhibitors come of age
16. Participation of p53 protein in the cellular response to DNA damage
17. A measure of genomic instability and its relevance to lymphomagenesis
18. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
19. Mechanism by which caffeine potentiates lethality of nitrogen mustard
20. A cancer family syndrome in twenty-four kindreds
21. Review article: Biology of melanoma invasion and metastasis
22. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies
23. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
24. Mutator phenotype may be required for multistage carcinogenesis
25. Oncology
26. Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells
27. Regulation of progression through the G1 phase of the cell cycle by the rum1 + gene
28. A novel cyclin encoded by a bcl1-linked candidate oncogene
29. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways
30. Premature chromosome condensation in a ts DNA-mutant of BHK cells
31. The clonal evolution of tumor cell populations
32. Amplified dihydrofolate reductase genes are localized to a homogeneously staining region of a single chromosome in a methotrexate resistant Chinese hamster ovary cell line
33. A restriction point for control of normal animal cell proliferation
34. The source of heritable variation in cellular growth capacities
35. Multiple mechanisms of N-(phosphonoacetyl)-l-aspartate drug resistance in SV40-infected precrisis human fibroblasts
36. Gene amplification, drug resistance, and cancer
37. Gene amplification and drug resistance in cultured murine cells
38. Association of multiple copies of the n-myc oncogene with rapid progression of neuroblastomas
39. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
40. Mutation rate of normal and malignant human lymphcocytes
41. Mammalian G1 cyclins
42. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
43. Gene amplification
44. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression
45. Loss of chromosomal integrity in neoplasia
46. Genomic integrity and the genetics of cancer
47. Mammary hyperplasia and carcinoma in MMTV-Cyclin D1 transgenic mice
48. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae
49. Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage
50. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins
51. p21 is a universal inhibitor of cyclin kinases
52. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles